Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4507f11e67f5530951bb46932db22c24 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-39 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 |
filingDate |
2011-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01b0fbf60fd93b68f521e1bc0cc86918 |
publicationDate |
2014-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2014017208-A1 |
titleOfInvention |
Glp-1 receptor agonists for islet cell transplantation |
abstract |
The disclosure provides methods for treating diabetes by promoting graft survival and improved graft function in a patient receiving an islet transplant by treating the patient with a GLP-1 receptor agonist compound prior to the islet transplant. The methods may also comprise treating the islets with a GLP-1 receptor agonist compound prior to transplanting them in a patient. The methods may eliminate the need for immunosuppressive therapy in islet transplants. Any GLP-1 receptor agonist compound know in the art can be used in the methods described herein. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9775904-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9670261-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9771406-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9932381-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9758561-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9751926-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9750788-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019042391-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9745360-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018256323-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10806797-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10758592-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9694053-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10253079-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9982029-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9789165-B2 |
priorityDate |
2010-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |